The Artima Developer Community
Articles | News | Weblogs | Books | Forums
Artima Forums | Articles | Weblogs | Java Answers | News
Sponsored Link •

Java Buzz Forum
Drug for Diabetic Nephropathy in Phase 3 Trial

0 replies on 1 page.

Welcome Guest
  Sign In

Go back to the topic listing  Back to Topic List Click to reply to this topic  Reply to this Topic Click to search messages in this forum  Search Forum Click for a threaded view of the topic  Threaded View   
Previous Topic   Next Topic
Flat View: This topic has 0 replies on 1 page
Angsuman Chakraborty

Posts: 19816
Nickname: angsuman
Registered: Dec, 2003

Angsuman Chakraborty is the CEO and Chief Architect at Taragana
Drug for Diabetic Nephropathy in Phase 3 Trial Posted: Jul 7, 2005 11:25 AM
Reply to this message Reply

This post originated from an RSS feed registered with Java Buzz by Angsuman Chakraborty.
Original Post: Drug for Diabetic Nephropathy in Phase 3 Trial
Feed Title: Simple Thoughts on Java
Feed URL: http://sedoparking.com/search/registrar.php?domain=®istrar=sedopark
Feed Description: News and views as a Software Architect and Entepreneur on Java and related Technologies. 		Latest Java Buzz Posts
Latest Java Buzz Posts by Angsuman Chakraborty
Latest Posts From Simple Thoughts on Java

Advertisement
Speedel announced today the start of its Phase III study for SPP301, its once-a-day oral endothelin A receptor antagonist (ERA) in the indication of diabetic nephropathy (diabetic kidney disease). The ASCEND(1) study has begun with the first patient visit as per the schedule outlined by Speedel in March 2005 when the company reported successful completion [...]

Read: Drug for Diabetic Nephropathy in Phase 3 Trial

Topic: Warren Buffett Eyes Indian Stock Market Previous Topic   Next Topic Topic: Thoughts on a SOA, part 2: It’s not Remoting
Sponsored Links


Google
  Web Artima.com   

Copyright © 1996-2019 Artima, Inc. All Rights Reserved. - Privacy Policy - Terms of Use